The Sun Will Be Shining in the Pain Management Sky
Journal of Cellular & Molecular Anesthesia,
Vol. 8 No. 2 (2023),
26 February 2023
,
Page 71-72
https://doi.org/10.22037/jcma.v8i2.41433
Abstract
Keywords:
- Pain
- Novel Aspects
How to Cite
1.
Karimian M, Dabbagh A. The Sun Will Be Shining in the Pain Management Sky. J Cell Mol Anesth [Internet]. 2023 Feb. 26 [cited 2023 Oct. 1];8(2):71-2. Available from: https://journals.sbmu.ac.ir/jcma/article/view/41433
References
1. Looking forward 25 years: the future of medicine. Nat Med. 2019;25(12):1804-7.
2. Dabbagh A. Anesthesiomics: Could a New Name Be Coined for Anesthesia? Anesth Pain Med. 2020;10(1):e100988.
3. Fillingim RB, Kaplan L, Staud R, Ness TJ, Glover TL, Campbell CM, et al. The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J Pain. 2005;6(3):159-67.
4. Kong Y, Yan T, Gong S, Deng H, Zhang G, Wang J. Opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) and postoperative nausea and vomiting. Am J Transl Res. 2018;10(9):2764-80.
5. Taqi MM, Faisal M, Zaman H. OPRM1 A118G Polymorphisms and Its Role in Opioid Addiction: Implication on Severity and Treatment Approaches. Pharmgenomics Pers Med. 2019;12:361-8.
6. Indra B, Lipoeto NI, Tjong DH, Rahman S. Polymorphism of Gene OPRM A118G and COMT G158A and Pain Sensitivity of the Minangkabau Ethnic, Indonesia. J Cell Mol Anesth. 2023;8(2):73-83.
7. Lötsch J, Ultsch A, Mayer B, Kringel D. Artificial intelligence and machine learning in pain research: a data scientometric analysis. Pain Rep. 2022;7(6):e1044.
8. Amaya F. Immunotherapy for the management of cancer pain. Ann Palliat Med. 2020;9(4):1358-60.
9. Taheran L, Zali H, Sharifi K, Yazdani M, Ajoudanian M, Safari MS, et al. Inhibitory Effects of Dutasteride on TLR4: An In vitro Pain Study. Iran J Allergy Asthma Immunol. 2022;21(5):574-83.
10. Vosoughian M, Dabbagh A, Rajaei S, Maftuh H. The duration of spinal anesthesia with 5% lidocaine in chronic opium abusers compared with nonabusers. Anesth Analg. 2007;105(2):531-3.
11. Sun L, Lutz BM, Tao YX. The CRISPR/Cas9 system for gene editing and its potential application in pain research. Transl Perioper Pain Med. 2016;1(3):22-33.
12. Zhao L, Huang J, Fan Y, Li J, You T, He S, et al. Exploration of CRISPR/Cas9-based gene editing as therapy for osteoarthritis. Ann Rheum Dis. 2019;78(5):676-82.
13. Zhu M, Whittaker AK, Jiang X, Tang R, Li X, Xu W, et al. Use of Microfluidics to Fabricate Bioerodable Lipid Hybrid Nanoparticles Containing Hydromorphone or Ketamine for the Relief of Intractable Pain. Pharm Res. 2020;37(10):211.
14. Clark AJ, Menendez G, AlQatari M, Patel N, Arstad E, Schiavo G, et al. Functional imaging in microfluidic chambers reveals sensory neuron sensitivity is differentially regulated between neuronal regions. Pain. 2018;159(7):1413-25.
2. Dabbagh A. Anesthesiomics: Could a New Name Be Coined for Anesthesia? Anesth Pain Med. 2020;10(1):e100988.
3. Fillingim RB, Kaplan L, Staud R, Ness TJ, Glover TL, Campbell CM, et al. The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J Pain. 2005;6(3):159-67.
4. Kong Y, Yan T, Gong S, Deng H, Zhang G, Wang J. Opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) and postoperative nausea and vomiting. Am J Transl Res. 2018;10(9):2764-80.
5. Taqi MM, Faisal M, Zaman H. OPRM1 A118G Polymorphisms and Its Role in Opioid Addiction: Implication on Severity and Treatment Approaches. Pharmgenomics Pers Med. 2019;12:361-8.
6. Indra B, Lipoeto NI, Tjong DH, Rahman S. Polymorphism of Gene OPRM A118G and COMT G158A and Pain Sensitivity of the Minangkabau Ethnic, Indonesia. J Cell Mol Anesth. 2023;8(2):73-83.
7. Lötsch J, Ultsch A, Mayer B, Kringel D. Artificial intelligence and machine learning in pain research: a data scientometric analysis. Pain Rep. 2022;7(6):e1044.
8. Amaya F. Immunotherapy for the management of cancer pain. Ann Palliat Med. 2020;9(4):1358-60.
9. Taheran L, Zali H, Sharifi K, Yazdani M, Ajoudanian M, Safari MS, et al. Inhibitory Effects of Dutasteride on TLR4: An In vitro Pain Study. Iran J Allergy Asthma Immunol. 2022;21(5):574-83.
10. Vosoughian M, Dabbagh A, Rajaei S, Maftuh H. The duration of spinal anesthesia with 5% lidocaine in chronic opium abusers compared with nonabusers. Anesth Analg. 2007;105(2):531-3.
11. Sun L, Lutz BM, Tao YX. The CRISPR/Cas9 system for gene editing and its potential application in pain research. Transl Perioper Pain Med. 2016;1(3):22-33.
12. Zhao L, Huang J, Fan Y, Li J, You T, He S, et al. Exploration of CRISPR/Cas9-based gene editing as therapy for osteoarthritis. Ann Rheum Dis. 2019;78(5):676-82.
13. Zhu M, Whittaker AK, Jiang X, Tang R, Li X, Xu W, et al. Use of Microfluidics to Fabricate Bioerodable Lipid Hybrid Nanoparticles Containing Hydromorphone or Ketamine for the Relief of Intractable Pain. Pharm Res. 2020;37(10):211.
14. Clark AJ, Menendez G, AlQatari M, Patel N, Arstad E, Schiavo G, et al. Functional imaging in microfluidic chambers reveals sensory neuron sensitivity is differentially regulated between neuronal regions. Pain. 2018;159(7):1413-25.
- Abstract Viewed: 65 times
- PDF Downloaded: 54 times